These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7681622)

  • 1. Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect.
    Shimozawa N; Suzuki Y; Orii T; Moser A; Moser HW; Wanders RJ
    Am J Hum Genet; 1993 Apr; 52(4):843-4. PubMed ID: 7681622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human peroxisome-deficient disorders and pathogenic gene].
    Fujiki Y
    Rinsho Shinkeigaku; 1994 Dec; 34(12):1219-21. PubMed ID: 7539728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and molecular aspects of peroxisome-deficient disorders].
    Suzuki Y; Shimozawa N; Orii T
    Nihon Rinsho; 1993 Sep; 51(9):2353-8. PubMed ID: 7692118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
    Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
    J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation analysis of peroxisomal disorders and classical Refsum.
    Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
    Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
    Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A
    Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on genetic and molecular investigations of diseases with general impairment of peroxisomal functions.
    Bioukar EB; Deschatrette J
    Biochimie; 1993; 75(3-4):303-8. PubMed ID: 8507691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
    Suzuki Y
    No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human gene responsible for Zellweger syndrome that affects peroxisome assembly.
    Shimozawa N; Tsukamoto T; Suzuki Y; Orii T; Shirayoshi Y; Mori T; Fujiki Y
    Science; 1992 Feb; 255(5048):1132-4. PubMed ID: 1546315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.
    Brul S; Westerveld A; Strijland A; Wanders RJ; Schram AW; Heymans HS; Schutgens RB; van den Bosch H; Tager JM
    J Clin Invest; 1988 Jun; 81(6):1710-5. PubMed ID: 2454948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal disorders: clinical commentary and future prospects.
    Wilson GN; Holmes RD; Hajra AK
    Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
    Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D
    J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
    Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H
    Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal disorders: a review.
    Wanders RJ; Schutgens RB; Barth PG
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):726-39. PubMed ID: 7545216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular biology of peroxisome biogenesis].
    Fujiki Y
    Nihon Rinsho; 1993 Sep; 51(9):2336-42. PubMed ID: 8411711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.
    Yajima S; Suzuki Y; Shimozawa N; Yamaguchi S; Orii T; Fujiki Y; Osumi T; Hashimoto T; Moser HW
    Hum Genet; 1992 Mar; 88(5):491-9. PubMed ID: 1372585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction by gene expression of biochemical abnormalities in fibroblasts from Zellweger patients.
    Shimozawa N; Suzuki Y; Tomatsu S; Tsukamoto T; Osumi T; Fujiki Y; Kamijo K; Hashimoto T; Kondo N; Orii T
    Pediatr Res; 1996 May; 39(5):812-5. PubMed ID: 8726233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
    Brown FR; Voigt R; Singh AK; Singh I
    Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.